In the rapidly growing and innovative therapeutic area, how do clinical trial sponsors effectively navigate the multitude of unique intricacies involved in cell and gene therapy development? In a...
As pharmaceutical and biotech companies understand the value of cellular-level insights to further personalize patient care, advancements in genomic laboratory capabilities are growing in interest. ...
Laboratory assessments — from preclinical research through post-marketing surveillance — determine whether a cell-based therapy for cancer succeeds or fails.Showcasing our IQVIA Connected...
Given the multitude of nuances to consider when conducting a pediatric trail, it is vital that sponsor form a comprehensive strategy early in the trail design. Q2 Solutions' Charlie Fix along with...
Cell Reports article, with contributions from Martin Buchkovich, Q2 Solutions Genomics Highlights
Why a roadmap towards more sustainable science is essential to improve the environmental impact of pathology labs everywhere
Can advances in tech-enabled solutions and workflows optimize diagnostic analysis while reducing the burden on pathologists?
Supporting virtual clinical trials with laboratory services that focus on easing patient and site burden by way of innovative self-collection technology.
Hybrid and decentralized clinical trials (DCTs) are fast becoming the norm, but they often involve multiple vendors and service providers, presenting sponsors and CROs with new considerations on the...
You feel like a ball of anxiety from the beginning to the end of your clinical trials. You have so many competing priorities that you don’t have time to learn new technology. You want to build...